Home/Filings/4/0001140361-23-002785
4//SEC Filing

Ouimette Mike 4

Accession 0001140361-23-002785

CIK 0001746473other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 9:00 PM ET

Size

11.7 KB

Accession

0001140361-23-002785

Insider Transaction Report

Form 4
Period: 2023-01-23
Ouimette Mike
General Counsel & Corp. Sec'y
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-23$24.32/sh+10,000$243,20025,947 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-01-2310,00077,000 total
    Exercise: $11.86Exp: 2032-01-25Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-23$11.86/sh+10,000$118,60015,947 total
  • Sale

    Common Stock

    2023-01-23$34.19/sh20,000$683,8785,947 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-01-2310,00098,240 total
    Exercise: $24.32Exp: 2030-10-08Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
  • [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
  • [F3]25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Documents

1 file

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001822619

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:00 PM ET
Size
11.7 KB